The Leadership Team at Viridian Therapeutics is responsible for setting the strategic direction of the company, overseeing the development of RNA-based therapeutics, and ensuring alignment between clinical, financial, and operational goals. This team of executives includes the Chief Medical Officer, Chief Financial Officer, and President/CEO, who collaborate to drive innovation, secure funding, and guide research initiatives that enhance patient outcomes through advancements in microRNA technology.
View all